Press Releases :: BiomX, Inc. (PHGE)

Sep 18, 2024 8:00am EDT

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference

Sep 04, 2024 8:00am EDT

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 03, 2024 8:00am EDT

BiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024

Aug 16, 2024 10:55am EDT

UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 15, 2024 6:30am EDT

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates

Aug 15, 2024 6:30am EDT

BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 08, 2024 7:00am EDT

BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024

Jul 29, 2024 7:00am EDT

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Jul 10, 2024 6:30am EDT

BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock

May 30, 2024 4:50pm EDT

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Previous
1
2
3
4
5
6
7
8
9
10
…13
Next

Investor Contact Information

Company

BiomX, Inc.
708 Quince Orchard Rd
Suite 205
Gaithersburg, MD 20878
USA
info@biomx.com

Investor Relations

Ben Cohen
benc@biomx.com